The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice

[1]  J. Tabernero,et al.  A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells , 2013, Clinical Cancer Research.

[2]  R. Bristow,et al.  Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment , 2013, Laboratory Investigation.

[3]  Junjie Lu,et al.  Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients , 2013, International journal of cancer.

[4]  M. Tsao,et al.  Characterization of Lymphomas Developing in Immunodeficient Mice Implanted With Primary Human Non–Small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  J. Dick,et al.  Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus , 2012, PloS one.

[6]  Aik Choon Tan,et al.  Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.

[7]  D. Decaudin.  Primary human tumor xenografted models (‘tumorgrafts’) for good management of patients with cancer , 2011, Anti-cancer drugs.

[8]  L. Cope,et al.  Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts , 2011, PloS one.

[9]  O. Martínez-Maza,et al.  HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma , 2010, Immunologic research.

[10]  E. Barillot,et al.  Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors , 2010, Clinical Cancer Research.

[11]  S. Lam,et al.  Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy , 2010, Clinical Cancer Research.

[12]  Michael Becker,et al.  Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers , 2008, Clinical Cancer Research.

[13]  A. Vincent-Salomon,et al.  A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays , 2007, Clinical Cancer Research.

[14]  M. Gail,et al.  Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.

[15]  V. Tarantul,et al.  Virus-Associated Lymphomagenesis , 2006, International journal of biomedical science : IJBS.

[16]  R. Ambinder.  Epstein-Barr virus-associated lymphoproliferative disorders. , 2003, Reviews in clinical and experimental hematology.

[17]  M. Rowe,et al.  Epstein–Barr Virus and Cancer , 2001 .

[18]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[19]  S. Eming,et al.  Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. , 1992, The American journal of pathology.

[20]  Carsten Denkert,et al.  Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Mosier.  Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. , 1991, Advances in immunology.